FDA and nanotechnology
This article was originally published in The Tan Sheet
Executive Summary
FDA will hold a meeting on nanotechnology in mid-October because it "is interested in learning about the kinds of new nanotechnology material products under development in the areas of food (including dietary supplements), food and color additives...cosmetics, drugs and biologics, and medical devices," the agency writes in an April 14 Federal Register notice. "Of particular interest to FDA, nanotechnology materials may enable new developments in implants and prosthetics, drug delivery, and food processing, and may already be in use in some cosmetics and sunscreens," the agency adds. FDA also is interested in "any other issues about which the regulated industry, academia and the interested public may wish to inform FDA concerning the use of nanotechnology materials in FDA-regulated products"...